相关实验视频
Updated: Mar 8, 2026

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.7K
门德尔的随机化研究发现,炎症性肠病和肝硬化之间没有因果关系
Jiawei An1, Mingyan Zhu, Yangsuolang Fu
1Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
Medicine
|March 6, 2026
概括
这项研究使用遗传数据来调查炎症性肠病 (IBD) 是否导致肝硬化. 这些发现表明,IBD并不直接导致肝硬化风险增加,这表明其他因素可能参与其中.
科学领域:
- 胃肠病学和肝病学
- 遗传流行病学遗传流行病学
背景情况:
- 观察性研究表明,炎症性肠病 (IBD) 与肝硬化风险增加之间存在联系.
- 在IBD和肝硬化中区分真正的因果关系和混因素是具有挑战性的.
- 门德尔随机化 (MR) 提供了一种方法来评估使用遗传变异的因果关系.
研究的目的:
- 研究炎症性肠病 (IBD) 对患肝硬化风险的潜在因果影响.
- 在IBD和肝硬化之间的关联中,区分直接因果关系和混影响.
主要方法:
- 进行了对两个样本的门德尔随机化 (MR) 分析.
- 对IBD的遗传仪器来源于IBD遗传学联盟.
- 肝硬化结局数据来自FinnGen和UK Biobank,并对总结统计数据进行了元分析.
主要成果:
- 主要MR分析 (反变量加权) 显示IBD对肝硬化风险没有显著的因果关系 (OR1.02,95% CI 0.97-1.07).
- 在多种MR方法 (MR-Egger,加权中位数) 中观察到一致的结果.
- 敏感性分析没有显示出显著的异质性或性,这支持了研究结果的稳定性.
结论:
- 该研究没有提供证据来支持炎症性肠病 (IBD) 与肝硬化风险增加之间的因果关系.
- 在之前的观察性研究中观察到的关联可能归因于混因素,而不是从IBD到肝脏疾病的直接因果途径.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
990
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
990
Inflammatory Bowel Disease II: Crohn's Disease
1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Inflammatory Bowel Disease I: Ulcerative Colitis
1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Chronic Bowel Disorders: Introduction
867
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
867
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
672
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
672
Irritable Bowel Syndrome I: Introduction
1.3K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.3K

